Literature DB >> 21955574

Open window thoracostomy and thoracoplasty to manage 90 postpneumonectomy empyemas.

Ilir Hysi1, Natacha Rousse, Antoine Claret, Jocelyn Bellier, Claire Pinçon, Frédéric Wallet, Rias Akkad, Henri Porte.   

Abstract

BACKGROUND: Postpneumonectomy empyema (PPE) is a serious complication. The treatment options are similar to the management of any abscess, with drainage, ideally open, often of critical importance. After infection control, many techniques for space obliteration have been described. This study summarizes a 10-year experience in the management of PPE in our center.
METHODS: From 2000 to 2010, 90 patients (83 men) with PPE were treated. Median follow-up was 5.3 years. Once the diagnosis of empyema was confirmed, chest drainage was performed through open window thoracostomy (OWT), with ensuing extramusculoperiosteal thoracoplasties if healthy tissue was present.
RESULTS: Pneumonectomy was performed in 72 patients with lung cancer. Mortality after PPE was 2.2%. OWT achieved infection control in 89 patients. Seven OWT spontaneously healed, and 24 were never closed. The remaining 59 patients with OWT underwent thoracoplasty. Mortality after thoracoplasty was 5%. Empyema recurred in 3 patients. Overall success rate of PPE control after pleural obliteration was 91.5%.
CONCLUSIONS: Thoracoplasty is a reliable filling procedure. It has a significantly higher success rate and a lower mortality rate than the other techniques. We believe that this procedure has a part to play in the future management of PPE. Copyright Â
© 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21955574     DOI: 10.1016/j.athoracsur.2011.07.004

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  [Tracheal injuries, fistulae from bronchial stump and bronchial anastomoses and recurrent laryngeal nerve paralysis : management of complications in thoracic surgery].

Authors:  S Welter; D Cheufou; K Darwiche; G Stamatis
Journal:  Chirurg       Date:  2015-05       Impact factor: 0.955

2.  Thoracomyoplasty for Chronic Empyema and Osteoradionecrosis of the Chest Wall

Authors:  Jeong In Hong; Hong Ju Shin; Won-Min Jo; Jae Seung Shin; Jinwook Hwang
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2020-11-25

3.  Reconstructive Surgery for Bronchopleural Fistula and Empyema: New Application of Free Fascial Patch Graft Combined with Free Flap.

Authors:  Minoru Sakuraba; Hiroki Umezawa; Shimpei Miyamoto; Masahide Fujiki; Takuya Higashino; Azusa Oshima; Masahiro Tsuboi
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-01-17

4.  Modified Clagett Procedure Is Effective for Methicillin-Resistant Staphylococcus aureus Postpneumonectomy Empyema: A Case Report.

Authors:  Stefan Welter; Sandra Kampe; Jan Dziobaka; Eleftherios Chalvatzoulis; Mahmood Zahin; Christian Roesel; Georgios Stamatis
Journal:  World J Oncol       Date:  2014-08-25

5.  An 83-year-old-male with bronchopleural fistula and empyema successfully treated with multidisciplinary management of thoracostomy, endoscopic, and surgical treatment: a case report.

Authors:  Zhongliang He; Lifeng Shen; Weihua Xu; Xiaowen He
Journal:  Ann Transl Med       Date:  2021-03

6.  Treatment of Fungal Empyema Combined with Osteoradionecrosis by Thoracoplasty and Myocutaneous Flap Transposition.

Authors:  Joon Seok Lee; In Kyu Park; Samina Park; Kwan Yong Hyun; Chang Hyun Kang; Young Tae Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2018-08-05

7.  Effective treatment of bronchopleural fistula with empyema by pedicled latissimus dorsi muscle flap transfer: Two case report.

Authors:  Zhongliang He; Lifeng Shen; Weihua Xu; Xiaowen He
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

8.  Multidisciplinary team approach on a case of bronchopleural fistula after video-assisted thoracoscopic segmentectomy: a case report.

Authors:  Yonghua Sang; Yongbing Chen; Zengli Zhang; Jiucheng Shen; Jun Wang; Long Zhao; Xingshi Gu; Cheng Long; Liang Zhou; Haiyong Gu; Chang Chen
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.